← All companies

CMPX

Compass Therapeutics, Inc.

CMPX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.89

-0.06 -2.84%

Key statistics

from XBRL data in SEC filings

Market cap

$339M

Revenue (TTM)

$0.00

Net income (TTM)

-$68.2M

EPS (TTM)

$-0.40

P/E ratio

—

Dividend yield

—

Free cash flow

-$49.2M

Cash

$55.2M

Total assets

$205M

Gross margin

—

52-week range

$1.61 – $6.88

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 1, 2026 8-K Amended charter or bylaws Jun 23, 2026 8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Regulation FD disclosure; Other events Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Results of operations (earnings release); Other events Jan 6, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Other events Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 11, 2025 8-K Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Regulation FD disclosure; Other events Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Results of operations (earnings release); Other events Jan 8, 2025 8-K Director or officer change; Regulation FD disclosure Dec 10, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Shareholder vote results Jun 17, 2024 8-K Director or officer change; Regulation FD disclosure May 28, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Regulation FD disclosure Apr 25, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Director or officer change; Other events Jan 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 5, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023 8-K Shareholder vote results Jun 15, 2023